LONGEVITY HEALTH HOLDINGS IN (XAGE) Stock Price & Overview
NASDAQ:XAGE • US1429221294
Current stock price
The current stock price of XAGE is 2.32 USD. Today XAGE is down by -15.33%. In the past month the price decreased by -3.33%.
XAGE Key Statistics
- Market Cap
- 4.13M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -8.52
- Dividend Yield
- N/A
XAGE Stock Performance
XAGE Stock Chart
XAGE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to XAGE.
XAGE Earnings
XAGE Forecast & Estimates
XAGE Groups
Sector & Classification
XAGE Financial Highlights
Over the last trailing twelve months XAGE reported a non-GAAP Earnings per Share(EPS) of -8.52. The EPS increased by 66.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -193.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
XAGE Ownership
XAGE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.8 | 388.432B | ||
| AMGN | AMGEN INC | 16.04 | 197.413B | ||
| GILD | GILEAD SCIENCES INC | 16.4 | 179.993B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.21 | 119.226B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.95 | 78.843B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.01 | 41.564B | ||
| INSM | INSMED INC | N/A | 30.069B | ||
| BIIB | BIOGEN INC | 11.29 | 26.644B | ||
| NTRA | NATERA INC | N/A | 26.624B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.95 | 23.498B | ||
| MRNA | MODERNA INC | N/A | 20.758B | ||
| EXAS | EXACT SCIENCES CORP | 340.74 | 19.77B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.798B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About XAGE
Company Profile
Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 15 full-time employees. The company went IPO on 2021-07-29. The firm has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.
Company Info
IPO: 2021-07-29
LONGEVITY HEALTH HOLDINGS IN
2403 Sidney Street, Suite 300
Pittsburgh PENNSYLVANIA US
Employees: 15
Phone: 14128948248
LONGEVITY HEALTH HOLDINGS IN / XAGE FAQ
What does LONGEVITY HEALTH HOLDINGS IN do?
Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 15 full-time employees. The company went IPO on 2021-07-29. The firm has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.
What is the current price of XAGE stock?
The current stock price of XAGE is 2.32 USD. The price decreased by -15.33% in the last trading session.
What is the dividend status of LONGEVITY HEALTH HOLDINGS IN?
XAGE does not pay a dividend.
How is the ChartMill rating for LONGEVITY HEALTH HOLDINGS IN?
XAGE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Should I buy XAGE stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on XAGE.
What is the outstanding short interest for LONGEVITY HEALTH HOLDINGS IN?
The outstanding short interest for LONGEVITY HEALTH HOLDINGS IN (XAGE) is 0.2% of its float.